PubMed Health⌕ Search

Biomedical subjects

D Himes

Publications and source records attributed to D Himes.

11 recordsLinked to original sources

Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems.

BETA2/NeuroD1 is a bHLH transcription factor that is expressed during development in the mammalian pancreas and in many locations in the central and peripheral nervous systems. During inner ear ontogenesis, it is present in both sensory ganglion neurons and sensory epithelia. Although studies have shown that BETA2/NeuroD1 is important in the development of the hippocampal dentate gyrus and the cerebellum, its functions in the peripheral nervous system and in particular in the inner ear are unclear. Mice carrying a BETA2/NeuroD1 null mutation exhibit behavioral abnormalities suggestive of an inner ear defect, including lack of responsiveness to sound, hyperactivity, head tilting, and circling. Here we show that these defects can be explained by a severe reduction of sensory neurons in the cochlear-vestibular ganglion (CVG). A developmental study of CVG formation in the null demonstrates that BETA2/NeuroD1 does not play a primary role in the proliferation of neuroblast precursors or in their decision to become neuroblasts. Instead, the reduction in CVG neuron number is caused by a combination both of delayed or defective delamination of CVG neuroblast precursors from the otic vesicle epithelium and of enhanced apoptosis both in the otic epithelium and among those neurons that do delaminate to form the CVG. There are also defects in differentiation and patterning of the cochlear duct and sensory epithelium and loss of the dorsal cochlear nucleus. BETA2/NeuroD1 is, thus, the first gene to be shown to regulate neuronal and sensory cell development in both the cochlear and vestibular systems.

Acoustic Stimulation↗

Protein-calorie malnutrition and involuntary weight loss: the role of aggressive nutritional intervention in wound healing.

Protein-calorie malnutrition and involuntary weight loss continue to be prevalent among hospitalized and long-term care patients, particularly the elderly. Studies on nutritional intervention have established a correlation between nutritional status, body weight, and rate of wound healing. Nutritional intervention, however, must be provided early enough to prevent a catabolic-induced decline in lean muscle mass, which can further impair wound healing. Chronic, nonhealing wounds are particularly difficult to treat and contribute to significant morbidity, mortality, and hospitalizations. More aggressive nutritional management and a greater understanding of the role of nutrition and weight gain in wound healing can result in more effective patient care. This article discusses the role of protein-calorie malnutrition and involuntary weight loss in hindering the wound-healing process, and the need to establish an optimal anabolic environment for weight gain and improved wound healing.

Chronic Disease↗

Absence of ototoxicity of teichomycin A2 in guinea pigs.

Teichomycin A2 is a new antibiotic that is similar to vancomycin. Because vancomycin is reported to be ototoxic, teichomycin A2 was tested for ototoxicity. No evidence of ototoxicity was found. Furthermore, ethacrynic acid, a diuretic that augments the ototoxicity of many drugs, did not enhance ototoxicity with teichomycin A2.

Animals↗

A comparative study of the ototoxicity of gentamicin and gentamicin C1.

Dose-response experiments comparing the ototoxic liability of the aminoglycoside antibiotics gentamicin sulfate and gentamicin C1 sulfate were conducted on guinea pigs. Measures of cochlear electrophysiology, histology, and the pharmacokinetic disposition of the drugs in the plasma and perilymph were made. Electrophysiological and histological measures indicated that gentamicin is more ototoxic than is gentamicin C1.

Animals↗

Comparative ototoxicity of bumetanide and furosemide when used in combination with kanamycin.

The ototoxicity of bumetanide and furosemide was compared in Topeka strain guinea pigs pretreated with kanamycin. The animals, anesthetized with pentobarbital, received a single dose of 400 mg/kg kanamycin subcutaneously and the diuretics via indwelling catheter in the jugular vein 2 hours later. Ototoxic drug effects were determined by measuring the electrophysiological responses of the cochlea to sound stimuli and by determining the presence or absence of cochlear sensory hair cells from the organ of Corti. Both bumetanide and furosemide produced permanent alteration of cochlear activity in the kanamycin-pretreated animals. The ototoxic effect of bumetanide is five times that of furosemide on a milligram-for-milligram basis. The ototoxic potential of bumetanide is one eighth that of furosemide when the doses are adjusted for diuretic potency difference between the two diuretics.

Animals↗

Cochlear damage resulting from kanamycin and furosemide.

Permanent cochlear damage has been shown to occur in guinea pigs following the combined administration of kanamycin and furosemide. At the doses used, only a transient effect was measured with furosemide alone and no effect was detectable with kanamycin alone. This interaction results when a single subcutaneous dose of 400 mg/kg of kanamycin is followed in 2 hours by a single intravenous dose of furosemide. The dosage range for furosemide was 50 mg/kg for a just-detectable effect to 100 mg/kg for a very severe effect. Damage to the cochlea was ascertained by measures of the a.c. cochlear potential as well as surface preparation histology.

Animals↗

Nutritional supplements in the treatment of pressure ulcers: practical perspectives.

Because a pressure ulcer may be related to malnutrition, clinicians should assess patients' nutritional status and ensure that patients receive adequate nutrition to support healing. The Agency for Health Care Policy and Research's guideline Treatment of Pressure Ulcers outlines recommended calorie and protein levels for patients at risk for pressure ulcers and with pressure ulcers. This article focuses on practical aspects of providing adequate nutrition to patients with pressure ulcers, using a variety of products available for oral supplementation.

Dietary Proteins↗